AU760805B2 - Sample buffer and methods for high resolution gel electrophoresis of denatured nucleic acids - Google Patents

Sample buffer and methods for high resolution gel electrophoresis of denatured nucleic acids Download PDF

Info

Publication number
AU760805B2
AU760805B2 AU15671/02A AU1567102A AU760805B2 AU 760805 B2 AU760805 B2 AU 760805B2 AU 15671/02 A AU15671/02 A AU 15671/02A AU 1567102 A AU1567102 A AU 1567102A AU 760805 B2 AU760805 B2 AU 760805B2
Authority
AU
Australia
Prior art keywords
sample
sample buffer
buffer
volume
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU15671/02A
Other versions
AU1567102A (en
Inventor
Roumen A. Bogoev
Song-Hua Ke
Timothy V. Updyke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Life Technologies Corp
Original Assignee
NOVEX
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU22393/99A external-priority patent/AU741179B2/en
Application filed by NOVEX filed Critical NOVEX
Priority to AU15671/02A priority Critical patent/AU760805B2/en
Publication of AU1567102A publication Critical patent/AU1567102A/en
Application granted granted Critical
Publication of AU760805B2 publication Critical patent/AU760805B2/en
Assigned to INVITROGEN CORPORATION reassignment INVITROGEN CORPORATION Request to Amend Deed and Register Assignors: NOVEX
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Description

la This application has been divided from the specification of Australian Patent Application No. 22393/99.
This invention relates to sample buffers and methods for gel electrophoresis. More particularly this invention relates to sample buffers and methods that improve high resolution electrophoretic separation of denatured nucleic acids.
o.
10 Background Of the Invention Gel electrophoresis is commonly used to separate by molecular size biological molecules, such as deoxyribonucleic acid ribonucleic acid and proteins. To perform gel electrophoresis, a polymeric gel, such as polyacrylamide, is formed in a glass tube, or between spaced glass or plastic plates.
The tube or plates are then placed in a chamber along with anode and cathode elements at the top and bottom of the gel. Sample wells formed in the top of the gel are first filled with running buffer solutions, and then with molecule samples prepared in a sample buffer that may contain a tracking dye. Electrophoretic running buffer solutions containing conductive ions are added to the chamber to make electrical contact between 2 the gel, the samples in the wells and the anode and cathode elements. A voltage is then applied across the gel, which causes the sample molecules and any tracking dye to migrate toward the bottom of the gel, and separate into bands whose migration distance depends on molecular size.
The macromolecule migration rate through the gel generally depends upon five principle factors: the gel porosity; the applied electric field 10 strength; the electrophoresis temperature; the "macromolecule charge density; and the macromolecule size and shape. For reproducible high resolution electrophoresis, these five factors generally must be precisely controlled from gel-to-gel and from sample-to-sample.
The first four factors generally do not pose a significant problem for separating nucleic acids.
Manufactured precast electrophoresis gels may be used to maintain highly uniform gel-to-gel porosity, and 20 numerous gel types are available for separating different macromolecules. In addition, modern electrophoresis equipment accurately controls temperature and voltage during separation. Further, DNA and RNA charge densities are very uniform because of the repeating structure of the anionic phosphate backbone. This charge uniformity leads to a precise inverse correlation of mobility with molecular length or base number, allowing nucleic acids varying by one base unit to be resolved by electrophoresis.
DNA base sequencing is one of the most useful embodiments of denaturing gel electrophoresis separations. In DNA base sequencing, the DNA 3 sequencing product is denatured and the resulting single stranded DNA sample is applied to the electrophoresis gel. The native structural forms of DNA and RNA result from hydrogen-bonded interactions between complementary sequences of two strands of nucleic acid or between complementary regions in a single strand. These interactions must be completely *disrupted prior to and during electrophoresis to eliminate secondary structure so that precise i10 correlation of size with mobility is maintained.
Heat and organic solvents such as formamide and/or urea can be used in aqueous solutions to disrupt hydrogen bonds, resulting in denatured DNA and RNA.
Thus, denatured DNA separations typically are performed 15 in 6% polyacrylamide gels containing tris (hydroxy methyl) amino-methane, borate, ethylene diamine tetraacetic acid gel and running buffer, pH 8.3 to with 6 to 8 M urea and/or 2 to 12 M formamide acting as denaturants. In addition, DNA separations 20 typically are performed at high operating temperature, typically 45 to 55 0 C, to maintain fully denatured DNA.
DNA separations frequently are performed in gels 25 to 50 cm in length and about 0.4 mm thick, cast between two glass sheets. The gel is positioned vertically, and sample molecules, mixed after the sequencing reactions with a sample buffer concentrate, are applied into small sample wells near the top of the gel. These sample wells can be pre-formed in the gel or by use of a "sharks toothed comb," as described by Joseph Sambrook et al., Molecular Cloning: A Laboratory Manual 13.45-13.46 (2d ed. 1989) 4 The sample application area typically is filled with gel running buffer. The sample molecules, which are more dense than the running buffer, are carefully layered under the running buffer and on top of the exposed gel surface. To achieve sharp, well defined bands, the vertical depth of the sample should be minimized. Because DNA migrates faster in free solution in the loading buffer than it does in the gel, the DNA is concentrated and therefore sharpened at the 10 gel surface before it penetrates into the gel.
Nevertheless, dispersion and/or diffusion of the sample upward in the sample well will reduce the efficiency of this sharpening effect and limit the number of bases that can be clearly resolved on a given gel.
To increase resolution, electrophoresis may be performed using gels thinner than 0.4 mm, which create less band dispersion during electrophoretic migration. Recently, Novel Experimental Technology, Inc. ("NOVEX") developed the QuickPoint M precast 20 minigel (10 cm wide by 12.5 cm long and 0.25 mm thick) for DNA base sequencing. QuickPoint M is prepared with 6% polyacrylamide, 7M urea and a neutral pH buffer that provides stable electrophoresis and storage conditions.
QuickPoint' gels have very high resolution capabilities, and can be operated with voltage gradients greater than 100 volts/cm, which allows from 60 to over 100 DNA bases to be resolved in less than 10 minutes within an 11 cm gel.
To realize the potential separation efficiency of such thin gels, the sample bands must be very sharp from the beginning of the electrophoresis run. Because the gel is very thin, however, it is more 5 difficult to carefully layer the sample molecules on the gel and minimize dispersion during loading. Also, the sample molecules must be loaded quickly because the first few samples begin diffusing into the buffer and the gel before the final samples have been loaded and before electrophoresis commences. It is therefore an object of the present invention to provide a method for applying denatured nucleic acid samples to the sample wells in a denaturing electrophoretic gel to 10 maximize sample resolution and throughput.
Once electrophoresis begins and the molecules separate into bands, the bands may widen and begin to curve upward, further impairing fine resolution separation. Band sharpness and flatness are affected by, among other things, re-naturation and diffusion.
In addition, any free ions in the sample increase the conductance of the sample region, causing a low voltage drop across the sample region, which increases separation times and further impairs flatness and 20 sharpness.
Prior art electrophoresis systems use sample buffers to increase sample density and enhance band sharpness and flatness. High density samples quickly settle into the sample wells and speed sample loading, and consequently improve resolution. Ideally, an electrophoresis sample buffer provides several important functions: i. Controls sample zone pH during electrophoresis; 2. Controls ionand sample molecule movement during electrophoresis; 6 3. Increases sample density and/or viscosity to aid sample loading into the sample wells; 4. Provides tracking dye(s) to aid monitoring the progress of electrophoresis; 5. Provides denaturing agent(s) to disrupt macromolecules to their primary structure; and 6. Provides various chemical reducing and/or chelating agents to control sample 10 chemistries.
Prior art sample buffers that provide all six functions are commonly used in discontinuous, reducing, sodium dodecyl sulfate polyacrylamide gel electrophoresis ("SDS-PAGE") developed by U.K. Laemmli, 15 227 Nature 680-86 (1970), and by NOVEX, NOVEX Catalogue 59-73 (1996). In particular, these prior art sample buffers concentrate the sample molecules into very sharp starting zones. This process, called "stacking," is controlled by the common buffering ion contained in the buffer system comprised of the gel, sample buffer and running buffers. The common buffering ion typically is an amine or substituted amine, such as tris (hydroxy methyl) amino-methane ("Tris") or bis-(2hydroxyethyl) iminotris (hydroxymethyl) methane ("Bis- Tris"), respectively, with a pKa close to the desired pH of the buffer system for maximum pH control.
Stacking occurs when the anions used to titrate the Tris or Bis-Tris to the desired pH of the buffer system move faster than the sample molecules, and the anions in the running buffer are slower than the sample molecules. Under this condition, the sample 7 molecules become concentrated, or stacked, and the extent of the stacking effect is proportional to the concentration of the leading anions in the gel and/or sample buffer. Stacking enhances the subsequent sharpness of the separations, and is critical to high resolution electrophoresis.
Prior art sample buffers for denaturing nucleic acid electrophoresis, however, have not been designed to utilize this stacking effect. The primary reason is that the buffer systems used for nucleic acid electrophoresis generally are continuous, having the same buffering amines and titrating anions in the gel, running buffer and, occasionally, the sample buffer.
For example, NOVEX's TBE-Urea sample buffer contains TBE buffer; urea, which acts as a denaturant; ethylene diamine tetra-acetic acid which acts as chelating agent to bind divalent cations in the sample; and Ficoll" (type 400), a highly branched polysaccharide of 400 kDa that increases the sample 20 density and viscosity and retards molecular diffusion.
Further, prior art sample buffers for denaturing nucleic acid polyacrylamide gel electrophoresis have been developed to enhance ion chelation, but not necessarily to improve stacking.
For example, the Sequenase Version 2.0 DNA Sequencing Kit (United States Biochemical/Amersham Life Science) uses the most common prior art sample buffer (or stop solution) and method for denaturing DNA. These buffers contain 95% formamide; 20 mM EDTA, titrated with sodium hydroxide to pH 8.0; and 0.05% bromophenol blue and 0.05% xylene cyanol FF. Formamide acts as a denaturant, and EDTA acts as an ion-chelating 8 agent to bind magnesium ions, as required for sequencing enzyme activity and native DNA structure.
The Sequenasem method for denaturing DNA samples combines 3.5 volumes of sample molecules with 4 volumes of the sample buffer/stop solution, resulting in 10.7 mM EDTA and 51% formamide in the sample wells.
A common modification of the Sequenase method combines 6 volumes of sample molecules with 4 volumes of sample buffer/stop solution, resulting in 8 mM EDTA and 38% 10 formamide in the sample wells.
*o In addition, Tabor et al. U.S. Patent No.
4,795,699 ("Tabor") describes a DNA sequencing analysis in which a sample buffer containing 90% (volume/volume) formamide, 10 mM EDTA, and 0.10% (weight/volume) xylene cyanol is added to each sequencing reaction sample before gel electrophoresis. To prepare denatured DNA samples for sequencing analysis, Tabor's method combines 3 volumes of DNA sequencing reaction samples with 6 volumes of sample buffer, resulting in a 6.6 mM concentration of EDTA and 60% concentration of formamide in the sample wells of the sequencing gels.
Although the NOVEX TBE-urea sample buffer provides all but the stacking functions, and works reasonably well for standard denatured nucleic acid analyses, it does not provide maximum denaturing capacity when used in DNA sequencing. Additionally, TBE buffer has a relatively high pH that hydrolyzes the urea amide groups, thereby creating highly conductive ions, changes in pH and reductions in denaturing strength that cause non-uniform results.
Further, because all prior art sample buffers have pH ranges from 8 to 9, hydrolysis of urea and formamide is 9 a problem for all prior art sample buffers.
Moreover, prior art sample buffers containing EDTA are titrated by adding sodium hydroxide. However, sodium hydroxide produces free sodium ions, which increases sample conductance, slows separation, increases heat generation, and enhances convective mixing, and diffusion of sample molecules. It therefore also would be desirable to produce a neutral pH sample buffer that contains high EDTA concentration, but that 10 has low sample conductance.
Further, the Sequenase t M and Tabor sample buffers enhance ion chelation, but do not sufficiently increase sample solution density. In addition, both buffers increase conductivity and therefore increase separation time. It therefore would be desirable to provide a sample buffer that enhances ion chelation, increases sample solution density, and decreases sample solution conductivity.
Additionally, although prior art sample buffers achieve some stacking and ion chelation, such systems have not been optimized for this purpose. It therefore also would be desirable to produce a sample buffer that enhances electrophoresis resolution by completely denaturing the sample molecule, enhancing ion chelation and stacking, and inhibiting diffusion.
Summary of the Invention It is an object of this invention to provide a method for applying denatured nucleic acid samples to the sample wells in a denaturing electrophoresis gel to maximize sample resolution and throughput.
It is another object of this invention to 10 provide a neutral pH sample buffer that contains high EDTA concentration, but that has low sample conductance.
It is an additional object of this invention to provide a sample buffer that enhances ion chelation, increases sample solution density, and decreases sample solution conductivity.
It is a further object of this invention to produce a sample buffer that enhances electrophoresis resolution by completely denaturing the sample molecules, enhancing ion chelation and stacking, and inhibiting diffusion.
In accordance with this invention, applicants describe a sample buffer and method that maximizes g* denaturation, enhances ion chelation and stacking, and reduces diffusion. In addition, applicants describe a 1* gel electrophoresis method that maximizes sample resolution and throughput.
The above and other objects and advantages of 20 the present invention will be apparent upon consideration of the following detailed description.
Detailed Description Of The Invention Applicants describe a sample buffer and method that facilitates high resolution electrophoretic separation. Samples prepared using these sample buffers and methods exhibit enhanced band sharpness and flatness.
Sample buffers in accordance with this invention contain urea, formamide and a polysaccharide. The formamide and urea denatures the DNA sample and inactivates enzymatic activity in the 11 reaction mixtures. In addition, formamide and urea increase sample density, which causes the molecules in the samples to quickly sink in the sample wells and therefore enhance stacking.
As used herein, polysaccharide means two or more saccharides, and includes, but is not limited to disaccharides, linear polysaccharides and branched polysaccharides. Preferred embodiments of the sample buffer of the present invention include Ficoll
T
a 10 branched polysaccharide that increases density and slightly increases viscosity, and minimizes DNA and RNA diffusion into the walls of the sample well. Ficoll
T
also decreases the rate of complimentary DNA and RNA re-annealing, thereby producing homogeneous structural forms and improving band sharpness and flatness.
Persons of skill in the art would understand that other polysaccharides that would be useful in the buffer of the present invention include, but are not limited to, disaccharides such as sucrose and linear polysaccharides such as dextran.
Alternative embodiments of sample buffers of the present invention further include a primary or substituted organic amine and an acid such as a zwitterionic, inorganic or organic acid. Preferred sample buffers of the present invention include primary or substituted organic amines with a pKa of about 6.5 to titrated with a divalent cation chelating agent.
Preferably the primary or substituted organic amine is Tris or Bis-Tris. Persons of skill in the art would recognize that other primary or substituted organic amines that would be useful in the buffer of the present invention include, but are not limited to, to 12 N-(2-hydroxy-ethyl) morpholine, diethanolamine and triethanolamine.
Preferably, the acid is the divalent cation chelating agent EDTA. EDTA serves both as an ionchelating agent to remove magnesium ions, which are required for Sequenase M and other polymerases, and as a leading ion during gel electrophoresis to provide the initial transient stacking effect of DNA and RNA bands.
Persons of skill in the art would realize that other 10 acids would be useful in the buffer of the present invention. Such acids include, but are not limited to: organic acids such as formic acid, acetic acid and propionic acid; inorganic acids such as hydrochloric acid, phosphoric acid and sulfuric acid; and zwitterionic acids such as (2-(N-morpholino) ethanesulfonic acid) aspartic acid and glutamic acid.
Further alternative embodiments of the sample buffer of the present invention also include one or 20 more tracking dyes. Tracking dyes may be used to monitor the progress of electrophoresis and to indicate the positions of nucleic acids of a particular baselength. For instance, in the NOVEX 6% QuickPoint
T
gels, the bromophenol blue dye band migrates with 26 base-lengths of denatured DNA. Likewise, the acid red 4 dye co-migrates with 60 base-lengths and the xylene cyanol FF co-migrates with 110 base-lengths of denatured DNA. For some applications, however, such as automated DNA sequencing, tracking dyes should not be used because the dyes interfere with photometric detection of electrophoretically separated DNA molecules tagged with fluorescent dye molecules.
13 In embodiments of the sample buffer of the present invention, a sample buffer solution comprising a primary organic amine or substituted amine with a pK a of about 6.5 to 9.0, preferably between about 6.5 to 7.0, is titrated with EDTA, so that the pH of the sample buffer is between about pH 6.5 and pH preferably between about pH 6.5 to pH 7.5, and most 9*9** preferably pH 6.5 to pH The urea concentration may be about 6M (36% 10 weight/volume) to about 8M (48% weight/volume), preferably 7M (42% weight/volume). The formamide concentration may be about 30% to about (volume/volume), preferably about 40%. Branched polysaccharides of about 300 kDa to about 500 kDa, at a concentration of about 6% to about 18%, and most preferably branched polysucrose of about 300 kDa to about 500 kDa (Ficoll', type 400), are dense (approximately 1.4 to 1.6 g/mL) and highly soluble in water and polar organic solvents, such as formamide and 20 may increase viscosity.
Preferred embodiments of the sample buffer of the present invention contain 7M urea, 20-45% (volume/volume) formamide, 6-18% (weight/volume) Ficoll" (type 400), 21-50 mM EDTA (free acid), 100 mM-200mM Bis-Tris, and tracking dyes including 0.025% (weight/volume) xylene cyanol FF, 0.025% (weight/volume) bromophenol blue and 0.025% (weight/volume) acid red 4. Persons of skill in the art will recognize that all three dyes need not be used together and that other tracking dyes may be useful in the sample buffer.
14 The most preferred embodiment of the sample buffer of the present invention contains 7M urea, (volume/volume) formamide, 12% (weight/volume) Ficollm (type 400), 30 mM EDTA (free acid), 100 mM Bis-Tris, and tracking dyes including 0.025% (weight/volume) xylene cyanol FF, 0.025% (weight/volume) acid red 4 and 0.025% :(weight/volume) bromophenol blue, to form a solution having a density of 1.18 g/ml (20°C) and a pH of 10 In preferred methods for applying denatured nucleic acid samples to the sample wells in a denaturing electrophoretic gel, a sample solution first is prepared by combining 3 volumes of nucleic acid samples with 7 volumes of sample buffers of the present invention. Next, the sample solution is heated at 750C for 2 minutes and placed in an ice water bath for 2 minutes. Finally, about 0.2 pL to about 3 uL is pipetted into the top portion of each sample well. For gel thicknesses of about 0.25 mm, about 0.4 pl sample 20 solution is pipetted into the top portion of each sample well.
In particularly preferred methods, a sample solution first is prepared by combining 3 volumes of nucleic acid samples with 7 volumes of the most preferred sample buffer described above. The resulting sample solution contains 21 mM EDTA, 4.9 M urea, 28% formamide, 8.4% FicollT, and has a density of 1.13 g/ml (the same as pure formamide at 200C) and a relative viscosity of about 5 cP (200C). The sample solution is heated and then cooled as described above, and then about 0.2 pL to about 3 pL is pipetted into the top portion of each sample well. For gel thicknesses of 15 about 0.25 mm, about 0.4 pL sample solution is pipetted into the top portion of each sample well. The described methods are very fast and easy and result in sharp bands, long sequencing read-lengths of all loaded samples, and consequently high sample throughput.
These and other embodiments can be understood by reference to the following illustrative and comparative examples.
*o.
Examples o* 10 Bis-Tris was purchased from Research Organics (Cleveland, OH). EDTA, formamide, Ficoll T (type 400) and bromophenol blue were purchased from Sigma (St. Louis, MO). Urea was purchased from Amresco .e (Solon, OH). Acid red 4 was purchased from Aldrich Chemical Co. (Milwaukee, WI). Xylene cyanol FF was i purchased from Serva (Heidelberg, Germany). All other chemicals were reagent, "ultra pure" or "electrophoresis grade" from standard sources. DNA Sequencing gels, QuickPoint™, and running buffer were 20 from NOVEX (San Diego, CA). The gels were 6% polyacrylamide and contained 7M urea in a neutral pH buffer. The gels are manufactured a minigel format with dimensions 10 cm wide by 12.5 cm long with 0.25 mm spacers. Pipette tips (10 pL, flat and round designs) were purchased from Rainin (Woburn, MA).
DNA sequencing samples were prepared using a SequenaseT M Version 2.0 DNA Sequencing Kit from Amersham Life Science (Cleveland, OH). M13mpl8 single stranded DNA was used in the reaction as a template. The sequencing samples were labeled with dATP, aS, purchased from New England Nuclear (Boston, MA) 16 BioMax MR film purchased from Kodak (Rochester, NY) was used for autoradiographic visualization of the labeled DNA bands. The sequencing reactions were stopped by adding either the Sequenase T stop solution/sample buffer from the kit or various examples of our sample buffer invention. All samples were heated at 75 C for 2 minutes and chilled at 0°C in a ice water bath for 2 minutes before applying the samples to the wells of the sequencing gels by standard "underlay" pipetting 10 methods or the method according to our invention.
Electrophoresis was performed at 50°C in QuickPoint t Rapid DNA Sequencing Cell at 1200 V constant voltage according to the manufacturer's instructions and electrophoresis was stopped when the bromophenol blue dye reached the bottom of the gel (about 9 minutes). The gels were fixed and dried according to the manufacturer's instructions, and the DNA bands were visualized after exposing the film overnight.
Example 1 The preferred embodiment sample buffer for minigel DNA sequencing was prepared except that various concentrations of EDTA free acid (20, 30, 40, 50, 100 mM) were added to a constant amount of Bis-Tris free base (100 mM). The resulting sample buffer pH range was from 7.2 at 20 mM EDTA to 6.5 at 50 mM; at mM and higher concentrations of EDTA some portion of the EDTA remained insoluble and these sample buffers were not further tested. The remaining composition of the sample buffers was 7M weight/volume) urea, 17 (volume/volume) formamide, 12% (weight/volume) Ficoll T (type 400), 0.025% (weight/volume) bromopbenol blue, 0.025% (weight/volume) acid red 4, 0.025% (weight/volume) xylene cyanol FF. Four sets of DNA sequencing reactions were stopped by adding 7 volumes (14 pL) of the test sample buffers to 3 volumes (6 pL) of the reaction samples. In this example, the EDTA concentrations in final samples were 14 mM, 21 mM, 28 mM and 35 mM. The samples were heated, chilled and 10 applied to the top portion of the sample wells of the sequencing gels. Standard electrophoresis, processing and autoradiography were performed as above. The results showed that with 14 mM EDTA in the sample wells, the DNA base sequence could be read from 15 to 83 bases. With 21 mM to 35 mM EDTA, the bands were slightly sharper and the DNA sequences could be read from 83 to 85 bases. Therefore, the higher EDTA concentrations significantly improve the reading length of the sequencing gel.
20 Example 2 Applicants prepared two sets of DNA sequencing reactions. The first set was stopped by adding 7 volumes (14 pL) stop solution from the Sequenase t kit to 3 volumes (6 pL) of the sequencing reactions. The second set was stopped by adding 7 volumes (14 pL) of the preferred embodiment of the sample buffer to 3 volumes (6 pL) of the sequencing reactions. The samples were heated and then chilled by the standard method. The samples were aoplied as follows: 18 1. Samples prepared with the Sequenase TM stop solution were applied to two minigels using a prior art method: by inserting 170 um, flat pipette tips inside the wells and dispensing the samples on the bottom of the wells.
2. Samples prepared with the Sequenase7 stop solution were applied to two minigels using the preferred method of this invention: by touching the pipette tip on the top of the well and dispensing the 10 sample without inserting the tip inside the well.
3. Samples prepared with the preferred sample buffer were applied to two minigels using the preferred method of this invention.
The prior art loading method proved to be very difficult, taking more than 13 minutes to load both gels (8 sets of 4 samples). In particular, air bubbles from the pipette frequently became trapped in the sample wells and were difficult to remove. In addition, the samples dispersed and mixed with the buffer in the sample well, and an uneven sample quantity was dispensed when mixing occurred. As a result of these problems, the sequencing results were very inconsistent: between 0 and 76 bases were readable. Further, the bands were U-shaped, and some samples were unreadable as a result of DNA band fuzziness.
By contrast, the preferred method of this invention for applying the samples was fast and simple, requiring nnly 5.5 minutes to load both gels.
Significantly, however, the samples prepared wlth the 19 Sequenase t M stop solution produced fuzzy bands, which resulted in read lengths of approximately 62 bases.
Two samples applied to the final wells had sufficient sharpness to read 76 bases.
Samples prepared and loaded using the sample buffer and method of the present invention produced the sharpest and flattest bands. Indeed, the results showed consistently good quality across both gels (all 8 sets of samples), which resulted in read lengths of 10 83 bases.
These results, and those of Example 1, demonstrate that the sample buffer of the present invention significantly improves the sharpness and flatness of the DNA bands compared to the most common 15 prior art sample buffer, even when it is used in more concentrated amounts than the standard method. The results additionally show that even when we use a sample buffer containing 20 mM EDTA, which is the same
*.SS
concentration as the Sequenasem buffer solution, the 20 density increase caused by the polysaccharide improves performance.
The sample buffer and method of the present invention results in sample densities of about 1.13 g/mL, whereas samples prepared with the Sequenase™" stop solution and applied using the invented method have densities of about 1.09 g/mL. In addition, the presence of Ficoll7T in the samples provides a slight viscosity increase which decrease the dispersion and diffusion of the DNA molecules in the samples. By using the sample buffer and method of the present invention, DNA read lengths and sample throughpu. are increased.
20 Although the invention has been explained in relation to its preferred embodiments, it will be understood that various modifications thereof will become apparent to those skilled in the art. The foregoing disclosure is not intended to be construed to limit the present invention, or to otherwise exclude any such other embodiments, adaptions, variations and equivalent arrangements, the present invention being limited only by the claims appended hereto and the 10 equivalents thereof.
So.
*oooo

Claims (19)

1. A sample buffer for gel electrophoresis of denatured nucleic acid, the sample buffer comprising urea, formamide and a polysaccharide.
2. The sample buffer of claim 1 comprising about 7 M urea, from about 20% to about (volume/volume) formamide, and from about 6% to about 18% (weight/volume) polysaccharide.
3. The sample buffer of claim 2 comprising about 7 M urea, from about 30% to about '"(volume/volume) formamide, and from about 6% to about 18% (weight/volume) polysaccharide.
4. The sample buffer of claim 3 comprising about 7M urea, about 40% (volume/volume) formamide, and from about 6% to about 18% (weight/volume) polysaccharide. The sample buffer of any one of claims 1 4, comprising about 12% polysaccharide.
6. The sample buffer of any one of claims 1 wherein the polysaccharide is selected from the group consisting of disaccharides, linear polysaccharides and branched polysaccharides.
7. The sample buffer of claim 6 comprising about 6% to about 18% (weight/volume) branched polysaccharide.
8. The sample buffer of claim 7 comprising about 12% branched polysaccharide. -22-
9. The sample buffer of any one of claims 1 8, wherein the sample buffer has a pH of about 6.5 The sample buffer of claim 9, wherein the sample has a pH of about 6.5
11. The sample buffer of claim 10, wherein the sample buffer has a pH of about
12. The sample buffer of any one of claims 1 11, further comprising at least one tracking dye selected from the group consisting of xylene cyanol FF, acid red 4 and bromphenol blue.
13. The sample buffer of any one of claims 1 12, further comprising a component that results in stacking in a sample well of an electrophoretic gel.
14. The sample buffer of claim 13, wherein the "component that results in stacking comprises a primary or substituted organic amine and an acid selected from the group consisting of zwitterionic, inorganic and organic acids, wherein said organic amine is about 100 mM to about 200 mM bis-(2-hydroxyethyl) iminotris (hydroxymethyl) methane. The sample buffer of claim 14, comprising about 100 mM bis-(2-hydroxyethyl) iminotris (hydroxymethyl) methane.
16. The sample buffer of either of claims 14 wherein the organic acid is a divalent cation chelating agent. -23-
17. The sample buffer of claim 16, wherein the divalent cation chelating agent is ethylene diamine tetra-acetic acid.
18. The sample buffer of claim 17, comprising from about 21 mM to about 50 mM ethylene diamine tetra-acetic acid.
19. The sample buffer of claim 18 comprising about 30 mM ethylene diamine tetra-acetic acid. A sample composition for analysis by denatured nucleic acid electrophoresis, comprising; a nucleic acid; and a sample buffer according to any one of claims 1 19. .o 21. A method for applying a denatured nucleic acid sample to a sample well formed in a denaturing electrophoretic gel, the method comprising: preparing a sample composition by dissolving the nucleic acid sample in sample buffer according to any one of claims 1 denaturing the nucleic acid with heat; and pipetting the sample composition into an upper portion of the sample well.
22. The method of claim 21, wherein the preparing step comprises the steps of: preparing the sample composition by combining about 3 volumes of the nucleic acid sample with about 7 volumes of the sample buffer; -24- heating the sample composition for about 2 minutes at about 75°C; and cooling the sample composition for about 2 minutes in ice water.
23. A sample buffer for gel electrophoresis of denatured nucleic acid substantially as described with reference to the accompanying examples.
24. A method for applying a denatured nucleic acid sample Sto a sample well formed in a denaturing electrophoretic gel Ssubstantially as described with reference to the accompanying examples. DATED this 2 2 n d day of May, 2002 Novex By their Patent Attorneys I CULLEN CO *o o So S
AU15671/02A 1998-01-23 2002-02-19 Sample buffer and methods for high resolution gel electrophoresis of denatured nucleic acids Ceased AU760805B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU15671/02A AU760805B2 (en) 1998-01-23 2002-02-19 Sample buffer and methods for high resolution gel electrophoresis of denatured nucleic acids

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/012257 1998-01-23
AU22393/99A AU741179B2 (en) 1998-01-23 1999-01-22 Sample buffer and methods for high resolution gel electrophoresis of denatured nucleic acids
AU15671/02A AU760805B2 (en) 1998-01-23 2002-02-19 Sample buffer and methods for high resolution gel electrophoresis of denatured nucleic acids

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU22393/99A Division AU741179B2 (en) 1998-01-23 1999-01-22 Sample buffer and methods for high resolution gel electrophoresis of denatured nucleic acids

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2003236418A Division AU2003236418A1 (en) 1998-01-23 2003-08-21 Sample Buffer and Methods for High Resolution Gel Electrophoresis of Denatured Nucleic Acids

Publications (2)

Publication Number Publication Date
AU1567102A AU1567102A (en) 2002-04-11
AU760805B2 true AU760805B2 (en) 2003-05-22

Family

ID=3711573

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15671/02A Ceased AU760805B2 (en) 1998-01-23 2002-02-19 Sample buffer and methods for high resolution gel electrophoresis of denatured nucleic acids

Country Status (1)

Country Link
AU (1) AU760805B2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5370777A (en) * 1992-01-31 1994-12-06 Beckman Instruments, Inc. Capillary column containing removable separation gel composition and method of use
WO1995006668A1 (en) * 1993-09-03 1995-03-09 Fmc Corporation Nucleic acid sequencing gels

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5370777A (en) * 1992-01-31 1994-12-06 Beckman Instruments, Inc. Capillary column containing removable separation gel composition and method of use
WO1995006668A1 (en) * 1993-09-03 1995-03-09 Fmc Corporation Nucleic acid sequencing gels

Also Published As

Publication number Publication date
AU1567102A (en) 2002-04-11

Similar Documents

Publication Publication Date Title
Smith SDS polyacrylamide gel electrophoresis of proteins
Paulus et al. Analysis of oligonucleotides by capillary gel electrophoresis
Fung et al. High-speed DNA sequencing by using mixed poly (ethylene oxide) solutions in uncoated capillary columns
Walker Nondenaturing polyacrylamide gel electrophoresis of proteins
AU741179B2 (en) Sample buffer and methods for high resolution gel electrophoresis of denatured nucleic acids
Malá et al. Recent progress in analytical capillary isotachophoresis
US4589965A (en) Method for electroblotting
Xue et al. Determination of lactate dehydrogenase isoenzymes in single lymphocytes from normal and leukemia cell lines
Foret et al. Macrofluidic device for preparative concentration based on epitachophoresis
AU760805B2 (en) Sample buffer and methods for high resolution gel electrophoresis of denatured nucleic acids
Budowle et al. Discontinuous polyacrylamide gel electrophoresis of DNA fragments
US20100051459A1 (en) Denaturant-Free Electrophoresis of Biological Molecules Under High Temperature Conditions
US7276369B2 (en) Method for detecting a substance and microtiter plate
Foret et al. Ionic boundaries in biological capillary electrophoresis
Khandurina et al. Automated high-throughput RNA analysis by capillary electrophoresis
Zhang et al. Isoelectric focusing sample injection for capillary zone electrophoresis in a fused silica capillary
Kitagawa et al. Sample Preconcentration Protocols in Microfluidic Electrophoresis
Buckingham Resolution and Detection of Nucleic Acids
Kim et al. Capillary electrophoresis of DNA fragments using poly (ethylene oxide) as a sieving material
US7871507B2 (en) Medium for enhanced staining of single strand nucleic acids in electrophoresis
Catai et al. Influence of the electrokinetic injection conditions on the separation of DNA fragments in capillary electrophoresis
Kane et al. Blood group typing by electrophoresis based on isoelectric focusing
US20070240991A1 (en) Gelling Electrophoresis Loading Buffer
Jabasini et al. Low viscous separation media for genomics and proteomics analysis on microchip electrophoresis system
Kiba et al. Anomalously fast migration of triplet‐repeat DNA in capillary electrophoresis with linear polymer solution

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
HB Alteration of name in register

Owner name: INVITROGEN CORPORATION

Free format text: FORMER NAME WAS: NOVEX